Abstract
Lomitapide but not evolocumab reduces LDL-cholesterol to goal in homozygous familial hypercholesterolemia – 2 case reports
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.atherosclerosis.2023.06.427
Journal: Atherosclerosis | Publication Date: Aug 1, 2023 |
Lomitapide but not evolocumab reduces LDL-cholesterol to goal in homozygous familial hypercholesterolemia – 2 case reports
Join us for a 30 min session where you can share your feedback and ask us any queries you have